Figure 2From: Significant survival improvement of patients with recurrent breast cancer in the periods 2001-2008 vs. 1992-2000 Kaplan-Meier curves showing the overall survival rates for patients with (A) HR-positive/HER-2-negative, (B) HR-positive/HER-2-positive, (C) HR-negative/HER-2-positive, and (D) HR-negative/HER-2-negative tumors within the two cohorts.Back to article page